Wegovy Pill: What the Sales Surge Means for You
Novo Nordisk's oral semaglutide pill is selling far beyond early expectations, pushing the company's stock up sharply. For patients weighing GLP-1 options, this development raises real questions about access, cost, and whether a pill might work as well as the weekly injection. Here's what you need to know.